Thanks,

Its not only the drug co. that can be unscrupulous.

Regards

Peter MacIsaac
MacIsaac Informatics

Consulting in Health Informatics, Terminology & Data management and Health
Policy.

[EMAIL PROTECTED] 

0411403462 (mobile)
61611327 (office)
peter_macisaac (skype)

8 Ewart St. Yarralumla 2600

"We trained hard, but it seemed every time we were beginning to form up into
teams, we would be reorganised. I was to learn later in life that we tend to
meet any new situation by reorganising, and a wonderful method it can be for
creation the illusion of progress while producing confusion, inefficiency
and demoralisation." 

- From Pertonii Arbitri AD 66, attributed to Gaius Petronus, a Roman General
who later committed suicide. 


-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]
On Behalf Of Ken Harvey
Sent: Thursday, 9 March 2006 8:03 AM
To: General Practice Computing Group Talk
Cc: [EMAIL PROTECTED]
Subject: Re: [GPCG_TALK] Increase in Pathology / Radiology ordering

ABC Radio National Health Report, March 6, 2006, was the last of a 
3-part series on, "Cancer Screening, Benefits and Harms", see:

http://www.abc.net.au/rn/healthreport/stories/2006/1582008.htm#

The following transcript extract adds an additional reason why pathology 
tests are increasing.....

Alex Barratt: Dr Gil Welch, a physician with the US Department of 
Veterans Affairs.

Today we're going to look at how you might make your own decision about 
which cancers, if any, you want to be screened for. Before that though 
let's take a look at the forces that drive cancer screening. As we've 
seen over the last two weeks, cancer screening has some pretty big 
downsides. Yet almost everyone's strongly in favour of it. So the 
question is why there's so much public and professional enthusiasm for it.

Gilbert Welch: There's no single answer to that question. I think there 
are a number of explanations. Just the idea of early cancer detection is 
just so appealing. People are very genuinely scared by cancer and 
there's a widespread belief that gee there's no reason not to look for 
cancer early, and there's every reason to look for it early.

And this is part of a broader culture that uncritically accepts medical 
testing is a good thing, without recognising that testing does have 
downsides, that it does find things that otherwise wouldn't bother you, 
and that it can start a chain of events that's very difficult to stop.

Now I'd like to add a couple of other drivers, and it would not be 
correct not to bring up the topic of money. There are strong incentives. 
One of them is obviously for the test manufacturer or for the physicians 
that interpret them, whether they're mammographers or radiologists, 
they're good business right. Because they involve a lot of people, so 
they're big markets.

It's also become in the interests of medical centres to find cancer 
early. I'd like to read a quote by Otis Brawley, a urologist who went on 
to be a director of the Georgia Cancer Centre and worked at Emory 
University. He wrote that 'We at Emory had figured out that if we screen 
a thousand men at the North Lake Mall this coming Saturday we could bill 
Medicare and insurance companies for about 4.9 million dollars in health 
care costs'.

But he goes on to write that the real money comes later from the medical 
care that the wife will get in the next three years because Emory cares 
about her man, and from the money we'll get when he comes to Emory's 
emergency room when he gets chest pain. I think there's a lot of 
interest in garnishing patients, and one way to get patients is to offer 
free screenings.

Alex Barratt: Dr Gil Welch. One current example of a significant 
commercial opportunity is the test for human papilloma virus, the virus 
that causes cervical cancer. Not surprisingly the test is being strongly 
promoted by its makers, Digene who think it should be incorporated into 
cervical cancer screening because they argue it's good for women. But 
there's a lot of dispute about whether it would actually add anything to 
screening other than a lot of anxiety and cost.

Dr Angela Raffle is a world leader in research on cervical cancer 
screening, and she's had a close look at what Digene's been up to in 
promoting the HPV test.

Angela Raffle: The British medical Journal carried an article saying 
that perhaps we should solve all the problems in cervical screening by 
using HPV testing. And our newspapers are full of photographs of very 
well known celebrity women who apparently were campaigning for all 15 
European nation states to introduce HPV testing into the cervical 
screening program right away, Carol Smiley, Honour Blackman, Jilly 
Cooper. I think they would be the most prominent.

Well fortunately a very astute investigation of a journalist spotted 
that something strange seemed to be happening. And he contacted all the 
celebrities who were named on the website for the group. None of them 
knew that they had anything to do with the campaign. He managed to track 
down who'd set up the campaign which wasn't easy because it all traced 
back to a PO Box in Brussels. Nobody was allowed to divulge who'd set it 
up. But it turned out to be Burson-Marsteller which is a big PR company 
who were working on behalf of Digene, and they'd completely manufactured 
the whole celebrity group.

Alex Barratt: And they had done it to put pressure on governments in 
Europe and the UK, to include HPV testing as part of the screening program?

Angela Raffle: They'd done it precisely for that. And it creates the 
impression that oh well HPV testing must be a good thing because all 
these very high profile women must have independently looked at the 
evidence and made their minds up.

Alex Barratt: Dr Angela Raffle runs the NHS Breast and Cervical Cancer 
Screening Programs in Bristol, England.

Research in the prestigious journal of the National Cancer Institute 
found that 70% of US women and 60% of men had seen celebrity 
endorsements in the past year. About a quarter said the endorsements 
made them more likely to be screened.
-- 
Dr. Ken Harvey
Adjunct Senior Research Fellow
School of Public Health, La Trobe University
http://www.medreach.com.au
VOIP:  +61 (03) 9029 0634; Mobile +61 (04) 1918 1910
_______________________________________________
Gpcg_talk mailing list
[email protected]
http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk



_______________________________________________
Gpcg_talk mailing list
[email protected]
http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk

Reply via email to